Shareholding disclosure

AMR Action Fund GP, LLC

Declared position

15.978%

Threshold

Crossed upwards

Timeline

Published

18.02.2025

Transaction

07.02.2025

Voting rights breakdown

Voting rights acquired15.978%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

ZA01-000000000PRO3

Beneficial owner

AMR Action Fund GP, LLC

Declared address

AMR Action Fund GP, LLC, Boston, US

Listing

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

AMR Action Fund GP, LLC

BioVersys AG18.02.2025ZA01-000000000PRO3

Disclosure summary

AMR Action Fund GP, LLC disclosed a holding in BioVersys AG on the acquisition side, published by SIX Exchange Regulation on 18.02.2025, at 15.978% of voting rights. Notice category: Single shareholder.

Disclosed position

15.978%

Voting rights acquired

Voting rights acquired15.978%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

AMR Action Fund GP, LLC disclosed a holding in BioVersys AG, published on 18.02.2025.

Publication date18.02.2025

Transaction date07.02.2025

Issuing companyBioVersys AG

Beneficial ownerAMR Action Fund GP, LLC

Declared addressAMR Action Fund GP, LLC, Boston, US

CategorySingle shareholder

Voting rights acquired15.978%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDZA01-000000000PRO3

Conditions

Listing

Source: SIX Exchange Regulation · Publication date: 18.02.2025

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open